Percentage (%) of zero survival cases (persons)
| Country average (population) | Country average (country) | England | Scotland | Wales1 | Northern Ireland | Republic of Ireland | |
|---|---|---|---|---|---|---|---|
| All invasive xnmsc | 1.2% | 1.0% | 1.3% | 0.5% | 1.6% | 0.6% | |
| All xnmsc 0-24 | 0.2% | 0.1% | 0.2% | 0.0% | 0.0% | 0.0% | |
| All xnmsc 25-59 | 0.3% | 0.4% | 0.3% | 0.3% | 0.4% | 0.4% | |
| All xnmsc 60-79 | 0.8% | 0.7% | 0.9% | 0.4% | 1.0% | 0.4% | |
| All xnmsc 80+ | 3.0% | 2.5% | 3.2% | 1.0% | 4.1% | 1.5% | |
| All registrations | 0.8% | 0.6% | 0.8% | 0.3% | 1.0% | 0.3% | |
| Haematology | 1.4% | 1.0% | 1.5% | 0.4% | 1.6% | 0.6% | |
| Head and Neck | 0.4% | 0.3% | 0.4% | 0.2% | 0.4% | 0.0% | |
| Lower GI | 1.1% | 0.9% | 1.1% | 0.4% | 1.3% | 0.6% | |
| Upper GI | 1.3% | 1.1% | 1.4% | 0.4% | 2.4% | 0.2% | |
| HPB | 2.4% | 2.0% | 2.5% | 0.7% | 3.2% | 1.7% | |
| Trachea, Bronchus & Lung | 1.9% | 1.4% | 2.1% | 0.6% | 2.1% | 0.7% | |
| Melanoma of skin | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.0% | |
| Breast | 0.3% | 0.3% | 0.3% | 0.1% | 0.5% | 0.2% | |
| Cervix | 0.3% | 0.2% | 0.3% | 0.0% | 0.6% | 0.0% | |
| Other Female Genitals | 0.9% | 0.8% | 0.9% | 0.4% | 0.9% | 1.0% | |
| Prostate | 0.6% | 0.5% | 0.7% | 0.2% | 0.8% | 0.2% | |
| Kidney | 1.2% | 0.8% | 1.3% | 0.3% | 1.4% | 0.3% | |
| Bladder | 1.2% | 0.9% | 1.3% | 0.1% | 1.5% | 0.9% | |
| Brain and CNS | 0.6% | 0.6% | 0.7% | 0.2% | 1.4% | 0.0% | |
| Thyroid & other endocrine glands | 0.5% | 0.6% | 0.5% | 1.0% | 0.0% | 0.7% | |
| CUP | 6.7% | 5.8% | 7.0% | 3.8% | 8.8% | 3.6% | |
| Other invasive cancer | 2.1% | 2.2% | 2.0% | 1.5% | 3.2% | 2.1% | |
| Breast in situ | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Cervix in situ | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Other tumours | 0.8% | 0.6% | 0.9% | 0.1% | 1.2% | 0.1% |